FDA Issues Class I Recall for ED Drug Ingredients Due to Contamination

The FDA has initiated a Class I recall for sildenafil citrate and tadalafil, active ingredients used in compounded erectile dysfunction drugs. The recall stems from the presence of particulate matter and significant quality control failures at the manufacturing facility, Shoolin Pharma. This poses a serious risk of adverse health consequences, including blood vessel blockages and organ damage, highlighting critical safety concerns in drug manufacturing.